You are here

  • Home
  • Archive
  • Volume 5, Issue 6
  • Doxazosin was associated with more stroke and cardiovascular disease events than chlorthalidone in high risk hypertension

Article Text

Article menu
Download PDFPDF
Therapeutics
Doxazosin was associated with more stroke and cardiovascular disease events than chlorthalidone in high risk hypertension

https://doi.org/10.1136/ebm.5.6.172

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Sources of funding: National Heart, Lung, and Blood Institute and Pfizer. Medication supplied by Pfizer Inc, AstraZeneca, and Bristol-Myers Squibb.

    • For correspondence: Dr B R Davis, University of Texas-Houston, School of Public Health, 1200 Herman Pressler Street, Houston, TX 77030, USA. Fax +1 713 500 9530.

    • ↵* See glossary.

    • ↵† Davis BR, Cutler JA, Gordon DJ, et al. Am J Hypertens 1996;9:342–60.